Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06125743 · ClinicalTrials.gov registry record · NA
Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
A NA study of Lymphedema of the Head and Neck, sponsored by Abramson Cancer Center at Penn Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 2
- Study locations
NCT06125743 is a NA study of Lymphedema of the Head and Neck that is actively recruiting participants, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 204 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06125743, a NA study of Lymphedema of the Head and Neck, is actively recruiting participants, sponsored by Abramson Cancer Center at Penn Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL In-Person LEF-SMP
- BEHAVIORAL Telehealth LEF-SMP
Study Locations (2)
Pennsylvania
- University of Pennsylvania - Philadelphia
Tennessee
- Barbara Murphy - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2024-03-29 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06125743
The ClinicalTrials.gov registry entry for NCT06125743 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lymphedema of the Head and Neck appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.
NCT06125743 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06125743 about?
NCT06125743 is a clinical study titled "Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]". The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.
What is the current status of trial NCT06125743?
This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2024-03-29. Estimated completion is 2026-08-31.
What conditions does trial NCT06125743 study?
This clinical trial studies the following conditions: Lymphedema of the Head and Neck.
What interventions are being tested in trial NCT06125743?
The interventions under investigation include: Usual Care (BEHAVIORAL), In-Person LEF-SMP (BEHAVIORAL), Telehealth LEF-SMP (BEHAVIORAL).
Who is sponsoring clinical trial NCT06125743?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06125743 being conducted?
This trial has 2 study locations across Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema of the Head and Neck
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.